Literature DB >> 1481652

Hypothermia, Wernicke encephalopathy and multiple sclerosis.

C Geny1, P F Pradat, J Yulis, S Walter, D Cesaro, J D Degos.   

Abstract

Neurological exacerbation observed in MS patients is usually related to a demyelinating process. We report two patients where hypothermia (32.4 degrees C and 32.5 degrees C) and neurological exacerbation were probably due to a Wernicke encephalopathy (WE). The clinical features and the rapid efficiency of parenteral thiamine were suggestive of WE. Hypothermia is an exceptional symptom observed in MS and has been considered as resulting from hypothalamic demyelination; these two cases showed that WE which is another cause of reversible hypothermia, can be associated with MS.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1481652     DOI: 10.1111/j.1600-0404.1992.tb05501.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  5 in total

1.  Hypothermia due to hypothalamic involvement in multiple sclerosis.

Authors:  S Edwards; G Lennox; K Robson; A Whiteley
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-10       Impact factor: 10.154

2.  Hypothermia in multiple sclerosis.

Authors:  K D White; D J Scoones; P K Newman
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-10       Impact factor: 10.154

3.  Haematological, neurological and electrocardiographic findings in secondary hypothermia.

Authors:  Oana Dickinson; Brian Hanson; David G Benditt; Alisa M Duran-Nelson
Journal:  BMJ Case Rep       Date:  2012-11-15

4.  Thiamine deficiency-induced disruptions in the diurnal rhythm and regulation of body temperature in the rat.

Authors:  P J Langlais; T Hall
Journal:  Metab Brain Dis       Date:  1998-09       Impact factor: 3.584

5.  Hypothermia in Multiple Sclerosis: Beyond the Hypothalamus? A Case Report and Review of the Literature.

Authors:  Francesco Berti; Zeeshan Arif; Cris Constantinescu; Bruno Gran
Journal:  Case Rep Neurol Med       Date:  2018-03-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.